Allosteric Phosphatase Modulator / Anavo Therap - LARVOL DELTA

"#AnavoTherapeutics Launches with EUR 20 Million #SeedFinancing to Create Industry-Leading Pipeline of #AllostericPhosphataseModulators https://t.co/oMuyAmraps" (@1stOncology)

Anavo Therapeutics Launches with EUR 20 Million Seed Financing to Create Industry-Leading Pipeline of Allosteric Phosphatase Modulators (Businesswire) - "Anavo Therapeutics...debuted today with a EUR 20 million (approx. $24 million) seed financing...The funds will be used to advance a proprietary drug discovery portfolio in oncology and establish a versatile and robust platform to address the target space broadly across multiple indications...'Anavo was founded to unlock the full potential of phosphatase-targeting allosteric modulators and has attracted one of the largest European biotech seed rounds to date.'"

Financing • Oncology